Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
CAPRICOR THERAPEUTICS, INC. market cap for the quarter ending 2026-08-13 was $245.93M, a 31.21% decline year-over-year.
CAPRICOR THERAPEUTICS, INC. market cap for the quarter ending 2026-06-30 was $1.4B, a 208.69% increase year-over-year.
CAPRICOR THERAPEUTICS, INC. market cap for the quarter ending 2026-05-11 was $1.85B, a 454.18% increase year-over-year.
CAPRICOR THERAPEUTICS, INC. market cap for the quarter ending 2026-03-31 was $1.75B, a 303.88% increase year-over-year.
CAPRICOR THERAPEUTICS, INC. market cap for fiscal 2026 was $245.93M.
CAPRICOR THERAPEUTICS, INC. market cap for fiscal 2025 was $1.66B, a 163.31% increase from fiscal 2024.
CAPRICOR THERAPEUTICS, INC. market cap for fiscal 2024 was $629.04M, a 312.98% increase from fiscal 2023.
CAPRICOR THERAPEUTICS, INC. market cap for fiscal 2023 was $152.32M, a 56.33% increase from fiscal 2022.